Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 5.3% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours (CC) operates as a chemical company with a focus on titanium dioxide manufacturing. The company's stock displayed a notable uptrend in the market today.

Why is Chemours Company (The) going up?

CC stock is up 5.3% on Jan 22, 2026 17:11

  • Chemours' stock price surged by 8.2%, driven by the recent sale of its Taiwan titanium dioxide facility for $360 million. This transaction was viewed as a strategic move to bolster liquidity, reduce debts, and address existing obligations, thereby uplifting investor confidence in the company's financial position.
  • The divestment of the dormant manufacturing site is in line with Chemours' initiative to streamline its business portfolio, emphasizing core segments like advanced performance materials and sustainable solutions. This shift of resources towards innovative sectors likely resonated positively with investors, impacting the stock performance.
  • Insights derived from AI-driven analysis by market experts suggest a favorable market sentiment in the short and medium term for Chemours, highlighting an attractive risk-reward ratio and the potential for substantial returns. The positive market outlook, coupled with the company's strategic restructuring efforts, contributed to the bullish trend in Chemours' stock today.

CC Price Chart

CC Technical Analysis

CC News

Chemours (CC) Is Up 8.2% After Taiwan TiO₂ Sale Boosts Liquidity Flexibility Has The Bull Case Changed?

Chemours (CC) has seen an 8.2% stock increase following the US$360 million sale of its Taiwan titanium dioxide facility. This sale is expected to significantly improve the company's liquidity and aid in debt reduction, addressing PFAS-related uncertainties. While the sale doesn't alter fundamental demand or margins, it provides much-needed balance sheet flexibility and helps manage legacy liabilities.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/chemours-cc-is-up-82-after-taiwan-tio-sale-boosts-liquidity

0 News Article Image Chemours (CC) Is Up 8.2% After Taiwan TiO₂ Sale Boosts Liquidity Flexibility Has The Bull Case Changed?

Trading the Move, Not the Narrative: (CC) Edition

This article analyzes Chemours Company (NYSE: CC) using AI models to provide trading strategies. It highlights a strong near and mid-term sentiment, a 165.5:1 risk-reward setup targeting a 48.7% gain, and outlines position, momentum breakout, and risk hedging strategies.

https://news.stocktradersdaily.com/news_release/149/Trading_the_Move,_Not_the_Narrative:_CC_Edition_012126031001_1769026201.html

1 News Article Image Trading the Move, Not the Narrative: (CC) Edition

The Chemours Company to Sell Former Titanium Dioxide Site in Taiwan

The Chemours Company has signed definitive agreements to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan. The sale, valued at approximately $360 million, is expected to close by mid-2026, subject to regulatory approval, and the proceeds will be used to reduce Chemours' debt obligations. The dismantling and removal procedures for the site were completed in the first quarter of 2025.

https://www.coatingsworld.com/breaking-news/the-chemours-company-to-sell-former-titanium-dioxide-site-in-taiwan/

2 Missing News Article Image The Chemours Company to Sell Former Titanium Dioxide Site in Taiwan

Chemours agrees to sell former titanium dioxide site in Taiwan

Chemours has announced the sale of its inactive titanium dioxide manufacturing site in Taiwan as part of its strategy to optimize its portfolio and focus on core business areas. This divestment aims to streamline operations and reallocate resources towards innovation-driven sectors like advanced performance materials and sustainable solutions for the coatings industry. The move aligns with broader industry trends focusing on sustainability and efficiency, strengthening Chemours' competitive position.

https://www.european-coatings.com/news/markets-companies/chemours-agrees-to-sell-former-titanium-dioxide-site-in-taiwan/

3 News Article Image Chemours agrees to sell former titanium dioxide site in Taiwan

Chemours signs deal to divest former TiO₂ site in Taiwan

Chemours has signed definitive agreements to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan, to a group led by Century Wind Power and its affiliates. The deal is expected to generate approximately $360 million in gross cash proceeds, which will be used to reduce the company's debt obligations. The transaction is targeted to close by mid-2026, pending regulatory approvals.

https://www.fibre2fashion.com/news/chemical-announcement-news/chemours-signs-deal-to-divest-former-tio-site-in-taiwan-307799-newsdetails.htm

4 News Article Image Chemours signs deal to divest former TiO₂ site in Taiwan

Chemours Company (The) Price History

09.11.2025 - CC Stock was down 0.5%

  • The denial of Chemours' plea to secure confidential documents by a federal judge could lead to enhanced transparency but has also sparked concerns regarding potential negative impacts on investor sentiment from the information that may be divulged.
  • The appointment of Michael Foley as President of Titanium Technologies may indicate advancements in operations, yet investor apprehension persists due to persisting issues like PFAS litigation and regulatory uncertainties, resulting in a mixed response from the market.
  • The legal triumph of Carneys Point Township to pursue a billion-dollar cleanup lawsuit against chemical manufacturers, which includes Chemours, underscores the continuous legal hurdles faced by the company, further pressuring its stock performance.
  • The objection from Brunswick County commissioners to Chemours' expansion proposals stemming from worries about PFAS emissions and water contamination showcases mounting scrutiny and opposition from local authorities, introducing additional uncertainties to the company's future growth outlook.

15.11.2025 - CC Stock was down 5.0%

  • Michael Foley's appointment as the new president of Chemours' Titanium Technologies business signifies the company's commitment to enhancing profitability and operational efficiency.
  • The presence of hazardous "forever chemicals" such as GenX and TFA in the water supply, linked to Chemours' activities, has sparked concerns among experts and local authorities.
  • Reservations from local officials and environmental groups regarding Chemours' expansion intentions at its Fayetteville plant mirror a growing doubt about the company's capability to tackle PFAS contamination matters and prioritize public safety over production expansion.
  • The continued controversy surrounding Chemours' release of PFAS precursors and the possible health hazards related to TFA underscore the necessity for stricter regulations and transparency in the chemical sector to avert irreversible harm to the environment and communities.

22.00.2026 - CC Stock was up 5.3%

  • Chemours' stock price surged by 8.2%, driven by the recent sale of its Taiwan titanium dioxide facility for $360 million. This transaction was viewed as a strategic move to bolster liquidity, reduce debts, and address existing obligations, thereby uplifting investor confidence in the company's financial position.
  • The divestment of the dormant manufacturing site is in line with Chemours' initiative to streamline its business portfolio, emphasizing core segments like advanced performance materials and sustainable solutions. This shift of resources towards innovative sectors likely resonated positively with investors, impacting the stock performance.
  • Insights derived from AI-driven analysis by market experts suggest a favorable market sentiment in the short and medium term for Chemours, highlighting an attractive risk-reward ratio and the potential for substantial returns. The positive market outlook, coupled with the company's strategic restructuring efforts, contributed to the bullish trend in Chemours' stock today.

11.11.2025 - CC Stock was up 5.3%

  • Investors responded positively to the news of Michael Foley's appointment as the new President of Titanium Technologies at Chemours, fueling a bullish trend in the company's stock. This appointment is seen as a potential driver for operational enhancements and strategic changes.
  • Despite ongoing public health and environmental controversies linked to PFAS chemicals, including opposition to Chemours' expansion plans, investors seem to have focused more on the optimism surrounding Foley's leadership, resulting in a positive market sentiment.
  • The market sentiment towards Chemours appears to be balanced, with the potential positive impact of Foley's new role offsetting concerns related to PFAS contamination and regulatory challenges. This balancing act reflects a level of optimism for the company's future trajectory under Foley's leadership.
  • The increased investor confidence in Chemours may have been influenced by the denial of the company's request to seal documents related to PFAS discharges, suggesting a commitment to transparency and compliance, which could enhance trust and bolster investor sentiment.

21.00.2026 - CC Stock was up 6.5%

  • The sale of Chemours' former titanium dioxide manufacturing site in Taiwan for approximately $360 million is seen as a positive strategic move by investors, leading to increased confidence in the company's financial outlook.
  • By divesting the inactive site and using the proceeds to reduce debt obligations, Chemours is demonstrating a commitment to optimizing its portfolio and focusing on core business areas, which is well-received by the market.
  • Despite facing legal risks from a PFAS class action lawsuit, the company's proactive approach to strengthening its financial position through asset sales is viewed favorably by investors, overshadowing concerns about potential legal challenges.
  • The market's positive reaction to Chemours' debt reduction plans and strategic reallocation of resources reflects a growing emphasis on sustainability and efficiency in the industry, positioning the company for long-term growth and competitiveness.

06.00.2026 - CC Stock was up 5.3%

  • The bullish movement in CC stock today could be attributed to the projected growth in the PFA market, with an estimated value expected to reach US$ 626.3 million by 2030. This positive outlook indicates increasing demand for PFA due to its unique properties.
  • The environmental concerns raised by environmental groups urging Chemours CEO to pledge against mining near the Okefenokee Swamp might have also impacted the stock positively. By showing a commitment to environmental conservation, Chemours could be seen more favorably by investors and stakeholders.
  • The expansion of applications and capacities by key players like The Chemours Company in regions like Asia Pacific and North America could have further boosted investor confidence in the company's future prospects.

15.00.2026 - CC Stock was up 6.0%

  • The bullish movement in CC stock can be attributed to the positive outlook for the hafnium market, driven by evolving consumer demand and technological advancements.
  • The analysis of CC's volatility zones and trading strategies indicates a strong near-to-mid-term sentiment, contributing to the stock's bullish movement.
  • The efforts by North Carolina regulators to reduce PFAS and 1,4-Dioxane discharges, as well as the EPA's attempt to loosen federal PFAS rules, may have indirectly impacted CC's stock positively as investors seek companies adhering to stricter environmental regulations.
  • Overall, CC's bullish movement today reflects both internal factors such as trading strategies and external factors like regulatory developments in the environmental sector, contributing to the stock's positive performance.

16.11.2025 - CC Stock was down 6.7%

  • The stock of Chemours Company (CC) experienced a strong bearish movement today, possibly influenced by:
  • Concerns over the company's declining Q3 revenue, particularly in segments like Freon Refrigerants and Foam, Propellants & Other sales.
  • Negative sentiment stemming from the discovery of dangerous chemicals like GenX in the US water supply, traced back to a Chemours factory, raising environmental and health-related alarms.
  • Opposition from local authorities and utility organizations towards Chemours' expansion plans, reflecting ongoing public health concerns and the company's historical accountability issues.
  • These factors combined may have contributed to investor uncertainty and a bearish trend in CC's stock price.

16.00.2026 - CC Stock was up 8.0%

  • The sale of the former titanium dioxide manufacturing site in Taiwan for $360 million cash has positively impacted CC's financial stability and liquidity.
  • The strategic move to focus on core business areas and optimize market strategy following the sale could have boosted investor confidence in CC's future prospects.
  • Despite a recent EPS miss in Q3 2025, the company's management of its global manufacturing footprint and debt reduction efforts seem to have resonated well with investors, leading to the bullish market movement.

16.00.2026 - CC Stock was up 5.1%

  • Two investment firms upgraded their price targets for Chemours, reflecting a positive view on the company's performance and growth potential.
  • Chemours recently sold a titanium dioxide manufacturing site in Taiwan for $360 million, a move expected to enhance its financial position by reducing debt.
  • Despite a recent earnings per share disappointment in Q3 2025, analysts maintain a positive outlook on Chemours, particularly in the titanium dioxide sector, emphasizing its high-risk, high-reward investment nature.
  • The market reacted favorably to the asset sales and price target upgrades, fueling the upward momentum in Chemours' stock price.

08.00.2026 - CC Stock was up 5.2%

  • The bullish movement in CC's stock is likely due to the positive industry outlook for Perfluoroalkoxy Alkanes (PFA), with projections anticipating substantial growth driven by demand across different sectors.
  • While legal challenges persist, investors appear more interested in the company's growth potential and operational progress.
  • Although the expansion of legal exposure initially raised concerns, market trends indicate optimism towards CC's ability to manage obstacles and leverage growth opportunities in the PFA market.
  • External advocacy against mining near the Okefenokee Swamp may impact CC's operations, but market sentiment seems to be primarily influenced by the company's overall market prospects and growth potential in the PFA industry.

08.00.2026 - CC Stock was up 7.4%

  • Despite legal challenges regarding PFAS chemicals in firefighter gear, Chemours (CC) saw notable bullish momentum in the stock market.
  • There is a possibility that the market is reacting strongly to the PFAS risks mentioned in a class-action lawsuit, potentially overshadowing the company's growth prospects and portfolio optimization in valuable applications.
  • Investors appear to be considering the legal implications alongside Chemours' strategic objectives and growth drivers, reflecting a mixed outlook on the company's future performance.
  • The expanding market for Perfluoroalkoxy Alkanes (PFA) and growth forecasts in key industries could be influencing the positive market trend, presenting potential opportunities for Chemours to enhance its product offerings and market presence.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.